Cargando…

Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country

Evaluation of pharmaceutical systems performance is an essential prerequisite for promoting evidence-based policy-making and improvement in health system performance. This study attempts to evaluate the performance of Iran pharmaceutical system based on the world health organization (WHO)′s indicato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minaei, Hossein, Peikanpour, Mohammad, Yousefi, Nazila, Peymani, Payam, Peiravian, Farzad, Shobeiri, Nikta, Karimi Majd, Zahra, Shamsaee, Javad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059036/ https://www.ncbi.nlm.nih.gov/pubmed/32184884 http://dx.doi.org/10.22037/ijpr.2019.111636.13273

Ejemplares similares

Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
por: Fathi, Mahdieh, et al.
Publicado: (2023)

How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?
por: Shobeiri, Nikta, et al.
Publicado: (2022)

Impact of the Trade-Related Aspect of Intellectual Property Rights Agreement on Pharmaceutical Industry in Developing Countries: A Scoping Review
por: Fathi, Mahdieh, et al.
Publicado: (2021)

Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries
por: Kadkhodamanesh, Azin, et al.
Publicado: (2021)

How does external reference pricing work in developing countries: evidence from Iran
por: Babaie, Fatemeh, et al.
Publicado: (2023)

An investigation into the pharmaceutical advertising in Iranian medical journals
por: Yousefi, Nazila, et al.
Publicado: (2022)

Perceptions, experiences and expectations of physicians regarding the role of pharmacists in low-income and middle-income countries: the case of Tehran hospital settings
por: Alipour, Fatemeh, et al.
Publicado: (2018)

The Effect of Organizational Resilience and Strategic Foresight on Firm Performance: Competitive Advantage as Mediating Variable
por: Fathi, Mahdieh, et al.
Publicado: (2021)

Exploring health seeking behaviors for common cold management
por: Keshvari, Negin, et al.
Publicado: (2023)

Mapping the pharmaceutical situation in your country: First things first...
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2009)

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
por: Taheri, Saeed, et al.
Publicado: (2019)

How Much Iranian Parents Know of and How Well They Practice Regarding Antibiotics?
por: Sharif, Zahra, et al.
Publicado: (2021)

Information systems for mental health in six low and middle income countries: cross country situation analysis
por: Upadhaya, Nawaraj, et al.
Publicado: (2016)

Attributes Development for Pharmaceutical Subsidization: A Qualitative Study
por: Afsharmanesh, Gita, et al.
Publicado: (2020)

Efficacy and Safety of Dulaglutide Compared to Liraglutide: A Systematic Review and Meta-analysis in Patients with Type 2 Diabetes Mellitus
por: Taheri, Saeed, et al.
Publicado: (2019)

Distributor– Retailer Interface in Pharmaceutical Supply Chain: Service Quality Measurement Scale
por: Mehralian, Gholamhossein, et al.
Publicado: (2016)

Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status
por: Maniadakis, N., et al.
Publicado: (2017)

Pediatric Surgery and Anesthesia in Low-Middle Income Countries: Current Situation and Ethical Challenges
por: Pulvirenti, Rebecca, et al.
Publicado: (2022)

Teaching and Learning Obstetric Anaesthesia in Low- and Middle-Income Countries: Current Situation and Perspectives
por: Guasch, Emilia, et al.
Publicado: (2023)

Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
por: Nebot Giralt, Ariadna, et al.
Publicado: (2020)

Behavioural interventions to address rational use of antibiotics in outpatient settings of low‐income and lower‐middle‐income countries
por: Nair, Mohit M., et al.
Publicado: (2021)

Information flow in the pharmaceutical supply chain
por: Yousefi, Nazila, et al.
Publicado: (2015)

Assessing the Performance of Community Pharmacies in Iran by Measuring Responsiveness to Non-Medical Needs: An Application of WHO Responsiveness Framework
por: Afifi, Saba, et al.
Publicado: (2021)

An application of analytic network process model in supporting decision making to address pharmaceutical shortage
por: Zarei, Leila, et al.
Publicado: (2020)

The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries
por: Morgan, Steven G., et al.
Publicado: (2017)

An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country
por: Moosivand, Asiye, et al.
Publicado: (2021)

Investigation of the Group Purchasing Structure in the Field of Pharmaceuticals and Medical Devices: The Case of Public Pharmacies
por: Rahim, Mohammadreza, et al.
Publicado: (2023)

The pharmacists’ patient care process in community pharmacy setting: evidence from Iran
por: Zare, Marziyeh, et al.
Publicado: (2020)

Pharmaceutical quality assurance of local private distributors: a secondary analysis in 13 low-income and middle-income countries
por: Van Assche, Kerlijn, et al.
Publicado: (2018)

Threats posed by stockpiles of expired pharmaceuticals in low- and middle-income countries: a Ugandan perspective
por: Kamba, Pakoyo Fadhiru, et al.
Publicado: (2017)

Maternal mental health in primary care in five low- and middle-income countries: a situational analysis
por: Baron, Emily C., et al.
Publicado: (2016)

Situation analysis of procurement and production of multiple micronutrient supplements in 12 lower and upper middle‐income countries
por: Monterrosa, Eva C., et al.
Publicado: (2017)

Comparative study of COVID-19 situation between lower-middle-income countries in the eastern Mediterranean region
por: El Khamlichi, Sokaina, et al.
Publicado: (2022)

Medical debt during epidemics: A case for resolving the situation in low- and middle-income countries such as Kenya
por: Obengo, Tom
Publicado: (2023)

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
por: Ebrahimi, Narges, et al.
Publicado: (2023)

Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
por: Abolfazli, Seyyed Abolfazl, et al.
Publicado: (2019)

Preparation and pharmaceutical evaluation of glibenclamide slow release mucoadhesive buccal film
por: Bahri-Najafi, R., et al.
Publicado: (2014)

Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment
por: Afsharmanesh, Gita, et al.
Publicado: (2021)

Tobacco Control Progress in Low and Middle Income Countries in Comparison to High Income Countries
por: Anderson, Carrie L., et al.
Publicado: (2016)

Anthelmintic resistance. An overview of the situation in the Nordic countries
por: Ihler, Carl Fredrik
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u86de7n70oji3npuv33tfjh787